Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Pancreatic cancer has the worst prognosis of any human malignancy lymphocytes infiltration appears to be a major prognostic marker of the disease. There is a need to better characterise T-cells in pancreatic cancer to identify novel therapeutic strategies and stratify patients for current treatments. In this study, a multi-parameter analysis of eight human pancreatic cancer patients revealed novel characteristics of T-cells. Regulatory T-cell populations were characterized by a highly immunosuppressive states with high TIGIT and ICOS expression, and CD8 T-cells were either senescent or exhausted but with lower PD1 levels. These findings have been subsequently validated in a larger pancreatic cancer single-cell RNA sequencing dataset. These data suggest that the microenvironment of pancreatic cancer is extremely suppressive and could be a major driver of poor prognosis. This work identifies potential therapeutic targets and avenues that should be further investigated through rational design of clinical trials.

Type

Working paper

Publication Date

03/07/2020